Cyanobacterial Toxin Cylindrospermopsin: It’s Possible Pathway from Poisoning to Cancer Curing

Mini Review

Austin Biomol Open Access. 2016; 1(2): 1009.

Cyanobacterial Toxin Cylindrospermopsin: It’s Possible Pathway from Poisoning to Cancer Curing

El-Deeb NM*

Biopharmacetical Product Research Department, Genetic Engineering and Biotechnology Research Institute, Egypt

*Corresponding author: Nehal M El-Deeb, Biopharmacetical Product Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technology Applications, Egypt

Received: July 25, 2016; Accepted: November 07, 2016; Published: November 10, 2016

Abstract

Cyanobacterial allelopathic interactions were being increasingly emerged for the pharmaceutical and environmental significance of the bioactive molecules. The biosynthetic pathways, regulatory mechanisms and genes involved in the cyanobacterial toxic compounds synthesis were well understood in relation to biotoxins, whereas the cytotoxins were being less investigated. Cyanotoxins comprised a rich natural source of cytotoxic compounds with potentiation to target specific uptake transporters in cancer cells. Moreover, their unique structure provided opportunities to resolve organ-specific toxicity issues and improve the therapeutic index.

In this review, we will discuss the possible role of cyanobacterial Cylindrospermopsin as a novel anticancer drug by summarizing the existing biomedical evidence of its toxicity, presenting structure-activity interaction and discussing developmental perspectives.

Keywords: Cyanobacterial toxins; Cylindrospermopsin; Toxicity; Anticancer

Introduction

Cyanobacteria (blue-green algae), among the Gram-negative photosynthetic prokaryotes, appeared approximately 3.5 billion years ago [1], cyanobacteria contain large group members 150 genera and about 2000 species of considerable diversity in physiology, metabolism and morphology [2]. They are prokaryotic that found in nature as unicellular species or in colonies (Figure 1) and rapidly grows in different habitats as terrestrial, fresh water, and marine ecosystems [2]. In addition, cyanobacteria also grow under various extremely conditions as they could found in Antarctic lakes and both saline and hot springs. Cyanobacteria consider as the primary first level organisms in food chains in water ecosystems due to their photosynthetic capacity. They also play an important role in the marine nitrogen cycle and have a role in balancing nitrogen (N) and CO dynamics in the biosphere [3]. Besides this role, certain species of cyanobacteria in water reservoirs (toxic cyanobacterial water-blooms) produce diverse toxic secondary metabolites as defense mechanisms against environmental stress factors present in a marine environment [4]. It is well known the potent cyanotoxins dangerous side effects to human as acute liver damage, neurotoxicity, gastrointestinal disturbances and liver cancer, all of which are demonstrated [5,6]. However, recently and by studying the physicochemical properties of cyanotoxins, the pharmacologists identify these molecules as potent anticancer agents. Cyanobacterial toxins such as Lipo Poly Saccharide (LPS), Anatoxin-a, Cylindrospermopsin and Microcystins could be pharmacologically active [7,8].